API import dependence remains high as China supplies nearly 74%: Government
New Delhi: API import dependence remained high in 2024-25, with India importing bulk drugs, drug intermediates and active pharmaceutical ingredients worth about USD 4.35 billion, the government told the Rajya Sabha.
In a written reply,…